Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP806949.RAfRfu_ICfTHho-R-TmkYix7ZIJ2lw5koBz6VhaV4pXdk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP806949.RAfRfu_ICfTHho-R-TmkYix7ZIJ2lw5koBz6VhaV4pXdk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP806949.RAfRfu_ICfTHho-R-TmkYix7ZIJ2lw5koBz6VhaV4pXdk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP806949.RAfRfu_ICfTHho-R-TmkYix7ZIJ2lw5koBz6VhaV4pXdk130_provenance.
- NP806949.RAfRfu_ICfTHho-R-TmkYix7ZIJ2lw5koBz6VhaV4pXdk130_assertion description "[Previously, we suggested that imatinib incorporation into conventional chemotherapy as an alternative (imatinib interim therapy) might be a useful strategy for bridging the time to allogeneic stem cell transplantation (SCT) for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph(+) ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP806949.RAfRfu_ICfTHho-R-TmkYix7ZIJ2lw5koBz6VhaV4pXdk130_provenance.
- NP806949.RAfRfu_ICfTHho-R-TmkYix7ZIJ2lw5koBz6VhaV4pXdk130_assertion evidence source_evidence_literature NP806949.RAfRfu_ICfTHho-R-TmkYix7ZIJ2lw5koBz6VhaV4pXdk130_provenance.
- NP806949.RAfRfu_ICfTHho-R-TmkYix7ZIJ2lw5koBz6VhaV4pXdk130_assertion SIO_000772 15657178 NP806949.RAfRfu_ICfTHho-R-TmkYix7ZIJ2lw5koBz6VhaV4pXdk130_provenance.
- NP806949.RAfRfu_ICfTHho-R-TmkYix7ZIJ2lw5koBz6VhaV4pXdk130_assertion wasDerivedFrom befree-20140225 NP806949.RAfRfu_ICfTHho-R-TmkYix7ZIJ2lw5koBz6VhaV4pXdk130_provenance.
- NP806949.RAfRfu_ICfTHho-R-TmkYix7ZIJ2lw5koBz6VhaV4pXdk130_assertion wasGeneratedBy ECO_0000203 NP806949.RAfRfu_ICfTHho-R-TmkYix7ZIJ2lw5koBz6VhaV4pXdk130_provenance.
- befree-20140225 importedOn "2014-02-25" NP806949.RAfRfu_ICfTHho-R-TmkYix7ZIJ2lw5koBz6VhaV4pXdk130_provenance.